Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Bullish +65

Wall Street Thinks Intuitive Surgical Stock Can Soar Over 30%. Here's Why Analysts are Right.

📉 ISRG stock is down ~30% from early 2025 highs and trading near 52-week lows.

🎯 Wall Street analysts set an average price target of $570, implying a >30% upside from current levels.

🤖 The da Vinci surgical system reached 11,395 global installations by Q1 2026, up 12% year-over-year.

📈 Surgeries performed using da Vinci robots increased 17% year over year.

💰 Instruments, accessories, and services generate ~75% of revenue as annuity-like income streams.

📉 P/E ratio is currently 51x, down from a five-year average of 70x.

🕰️ Historical data shows the stock has recovered from similar magnitude drawdowns multiple times since IPO.

🛡️ Recurring revenue model provides resilience against temporary slowdowns in new system sales.

📅 Analysts recommend a long-term hold strategy rather than short-term trading.

🚀 The company is positioned to benefit from expanding use cases and increased patient demand.

Bullish Signals
  • Analysts project a price target of $570, indicating a potential recovery of over 30% from current lows.
  • The da Vinci system installed base grew 12% year-over-year to 11,395 units globally by Q1 2026.
  • Surgery volume using the robotic system rose 17% year-over-year, signaling strong market demand.
  • Approximately 75% of revenue comes from recurring instrument and service sales rather than one-time hardware.
  • The company has successfully navigated multiple significant drawdowns historically, suggesting resilience.
  • Long-term growth drivers include expanding use cases for the robot and increasing patient demand.
Risk Factors
  • The stock trades at a high P/E ratio of 51x, which may deter value-oriented investors.
  • The company does not pay a dividend, making it unsuitable for income-focused portfolios.
  • There is a risk that the stock could fall further before recovering from current depressed levels.
  • Intuitive Surgical was excluded from The Motley Fool's top 10 stocks list for immediate purchase.
Full Analysis
Intuitive Surgical (NASDAQ: ISRG) stock is currently trading near its 52-week lows, having declined approximately 30% from its early 2025 highs. Despite this drawdown, Wall Street analysts maintain an upbeat outlook with an average price target of $570, suggesting a potential recovery and gain of over 30% from current depressed levels. The article notes that while the company's P/E ratio is lofty at 51x, it has decreased from a five-year average of 70x. The company operates as an industry leader in surgical robotics with its da Vinci system, which had 11,395 units installed worldwide by the end of Q1 2026, representing a 12% year-over-year increase. Demand for the technology is robust, evidenced by a 17% rise in the number of surgeries performed annually. Crucially, Intuitive Surgical's revenue model relies heavily on annuity-like income streams from instruments, accessories, and services, which constitute roughly 75% of its top line. Historical data suggests that significant drawdowns are common for the stock, with the company recovering and pushing higher after similar declines in the past. Analysts believe that even a temporary slowdown in new system sales would not derail long-term prospects due to the recurring revenue nature of their business model. The article advises investors to view Intuitive Surgical as a long-term hold rather than a short-term trade, noting its decade-long opportunity in healthcare technology.